— Canadian Solar (NASDAQ: CSIQ) reported Q4 2019 earnings of $1.04 per share vs. $0.45 expected.
— Revenue rose 2% to $920 million vs. $865.46 million expected.
— GAAP net income attributable to Canadian Solar was $67.7 million, or $1.12 per share, compared to net income of $111.6 million, or $1.81 per share, in the fourth quarter of 2018.
— Total solar module shipments were 2,474 MW.
— Canadian Solar expects 1Q20 revenue to be $780 million to $810 million. Total module shipments pegged to be in the range of 2.15 GW to 2.25 GW.
— FY20 revenue is estimated to be $3.4 billion to $3.9 billion. Total module shipments are targeted to be in the range of 10 GW to 12 GW.
— The company plans to continue with its stock repurchase program as recent COVID-19-related panic-selling brought its equity valuation below book value.
— CSIQ stock, which hit a 52-week high ($25.35) on February 19, 2020, more than halved and plunged to a new yearly low ($12.00) last week.
After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the
Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through strategic partnerships and technological innovation. Its performance so
The COVID-19 pandemic raged through the first half of this year and continues to impact the world without signs of abating. Amid this health crisis, several companies reported strong results